SC 13D/A | 2022-05-27 | New Enterprise Associates 16, L.P. | GENOCEA BIOSCIENCES, INC. | - | - | EDGAR |
SC 13G/A | 2022-02-14 | COMMODORE CAPITAL LP | GENOCEA BIOSCIENCES, INC. | 3,079,756 | 5.4% | EDGAR |
SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | GENOCEA BIOSCIENCES, INC. | 3,431,740 | 5.8% | EDGAR |
SC 13G/A | 2022-02-14 | CITADEL ADVISORS LLC | GENOCEA BIOSCIENCES, INC. | - | 6.0% | EDGAR |
SC 13G/A | 2022-02-10 | GLAXOSMITHKLINE PLC | GENOCEA BIOSCIENCES, INC. | 5,861,389 | 9.9% | EDGAR |
SC 13D/A | 2021-04-14 | New Enterprise Associates 16, L.P. | GENOCEA BIOSCIENCES, INC. | 15,401,579 | 26.3% | EDGAR |
SC 13G | 2021-03-31 | COMMODORE CAPITAL LP | GENOCEA BIOSCIENCES, INC. | 2,871,624 | 5.4% | EDGAR |
SC 13G/A | 2021-02-16 | CITADEL ADVISORS LLC | GENOCEA BIOSCIENCES, INC. | - | 6.5% | EDGAR |
SC 13G/A | 2021-02-16 | UBS OCONNOR LLC | GENOCEA BIOSCIENCES, INC. | 1,769,170 | 3.3% | EDGAR |
SC 13G/A | 2021-02-12 | BIOTECHNOLOGY VALUE FUND L P | GENOCEA BIOSCIENCES, INC. | 2,786,937 | 5.3% | EDGAR |
SC 13G/A | 2021-02-12 | Vivo Opportunity, LLC | GENOCEA BIOSCIENCES, INC. | 613,437 | 1.2% | EDGAR |
SC 13G/A | 2021-02-12 | GLAXOSMITHKLINE PLC | GENOCEA BIOSCIENCES, INC. | 5,217,389 | 9.9% | EDGAR |
SC 13G | 2021-02-12 | Avoro Capital Advisors LLC | GENOCEA BIOSCIENCES, INC. | 33,613,444 | 10.0% | EDGAR |
SC 13D/A | 2020-08-03 | New Enterprise Associates 16, L.P. | GENOCEA BIOSCIENCES, INC. | 16,964,079 | 48.7% | EDGAR |
SC 13G | 2020-07-31 | CITADEL ADVISORS LLC | GENOCEA BIOSCIENCES, INC. | - | 6.4% | EDGAR |
SC 13G/A | 2020-02-28 | GLAXOSMITHKLINE PLC | GENOCEA BIOSCIENCES, INC. | 3,676,767 | 13.3% | EDGAR |
SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | GENOCEA BIOSCIENCES, INC. | 1,532,957 | 3.2% | EDGAR |
SC 13G/A | 2020-02-14 | Vivo Opportunity, LLC | GENOCEA BIOSCIENCES, INC. | 1,443,838 | 3.0% | EDGAR |
SC 13G/A | 2020-02-14 | GLAXOSMITHKLINE PLC | GENOCEA BIOSCIENCES, INC. | 3,676,767 | 7.7% | EDGAR |
SC 13G | 2020-02-13 | UBS OCONNOR LLC | GENOCEA BIOSCIENCES, INC. | 1,769,460 | 6.3% | EDGAR |